Skip to content

Impact of a smartphone application on smoking cessation: a randomized controlled trial

Impact of a smartphone application on smoking cessation: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11318024
Enrollment
5200
Registered
2018-05-17
Start date
2019-04-10
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette smoking Mental and Behavioural Disorders Mental and behavioural disorders due to use of tobacco

Interventions

The trialists will randomly assign 5200 smokers to either using the Stop-tabac application for smartphones for 6 months or to use a placebo application. Stop-tabac is a fully-automated application (“a
a calculator of cigarettes not smoked, money saved, and years of life gained 5. A module on nicotine replacement therapy that includes personalized feedback Follow-up after 1 week, 1 month and 6 month

Sponsors

University of Geneva
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Daily cigarette smoker 2. Has been a daily smoker for at least one year 3. >18 years old 4. Sets a target quit date within one month of enrollment and commits to quit on this date 5. Provides informed consent online 6. Commits to answer all follow-up questionnaires, and commits to use the app 7. Owns a smartphone with Android operating system and has regular access to the Internet 8. Provides a postal address and telephone number, and a valid e-mail address 9. Lives in Switzerland or in France

Exclusion criteria

Exclusion criteria: Prior use of the Stop-tabac app for smartphones (self-report)

Design outcomes

Primary

MeasureTime frame
Self-reported smoking cessation at 6 months (no puff of tobacco in the past 4 weeks). All data will be self-reported via online questionnaires. Participants can use any device to answer (smartphone, tablet, laptop, desktop). There will be no biochemical validation of smoking status. Assessed 4 times: at baseline, and 1 week, 1 month and 6 months after the participant’s target smoking cessation date.

Secondary

MeasureTime frame
1. Point prevalence of smoking abstinence at 6 months (no puff of tobacco in the previous 7 days) 2. Russell Standard (<5 cigarettes in the past 6 months plus no puff of tobacco in the past 7 days) 3. Abstinence of any tobacco and e-cigarette use at 6 months (no use in the previous 7 days) 4. Motivation to quit 5. Quit attempts (number and duration) 6. Confidence in ability to quit 7. Use of nicotine therapy 8. Use of e cigarettes and heated tobacco products All data will be self-reported via online questionnaires. Participants can use any device to answer (smartphone, tablet, laptop, desktop). There will be no biochemical validation of smoking status. Assessed 4 times: at baseline, and 1 week, 1 month and 6 months after the participant’s target smoking cessation date.

Countries

Switzerland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 27, 2026